SATURDAY, APRIL 21, 2018

Meningitis Research Foundation gathers extra support to battle disease

CEO Vinny Smith attended a conference in February focused on post-Ebola health strategies.
CEO Vinny Smith attended a conference in February focused on post-Ebola health strategies. | File photo

The Meningitis Research Foundation (MRF) acknowledged World Immunization Week by reporting progress in the hands-on training of health care workers in the nation of Malawi and partnerships with global and U.S. initiatives.

Having announced collaboration with the Global Meningococcal Initiative (GMI) on Sunday — World Meningitis Day — MRF also recently disclosed additional support from mPowering Frontline Health Workers, a program headquartered in Washington, D.C. which belongs to the USAID Global Development Alliance.

Altogether, the humanitarian agencies work to reduce maternal-fetal deaths caused by meningitis and/or septicemia. Mobile technology is playing an increasingly important role in training and continuing professional development for on-the-ground workers in affected nations.

MRF also reported that CEO Vinny Smith attended a London conference in February focused on post-Ebola health strategies alongside key ministry spokespersons from Liberia, Guinea, Uganda, Mali, Rwanda, Ghana, Senegal and Malawi.  

Private sector representatives at the event included GSK, Intrahealth, Orange and Medic Mobile. Charities consisted of World Vision, BBC Media Action and the International Rescue Committee. Representatives from USAID, the Department for International Development and the Bill and Melinda Gates Foundation were also in attendance.

MRF maintains operations via its offices located in Belfast, Bristol, Dublin, Edinburgh and Blantyre, the capital of Malawi.

Organizations in this Story

Meningitis Research Foundation

Want to get notified whenever we write about Meningitis Research Foundation ?
Next time we write about Meningitis Research Foundation, we'll email you a link to the story. You may edit your settings or unsubscribe at any time.